BIN1 knockdown rescues systolic dysfunction in aging male mouse hearts.
Maartje WesthoffSilvia G Del VillarTaylor L VoelkerPhung N ThaiHeather C SpoonerAlexandre D CostaPadmini SirishNipavan ChiamvimonvatEamonn James DicksonRose E DixonPublished in: Nature communications (2024)
Cardiac dysfunction is a hallmark of aging in humans and mice. Here we report that a two-week treatment to restore youthful Bridging Integrator 1 (BIN1) levels in the hearts of 24-month-old mice rejuvenates cardiac function and substantially reverses the aging phenotype. Our data indicate that age-associated overexpression of BIN1 occurs alongside dysregulated endosomal recycling and disrupted trafficking of cardiac Ca V 1.2 and type 2 ryanodine receptors. These deficiencies affect channel function at rest and their upregulation during acute stress. In vivo echocardiography reveals reduced systolic function in old mice. BIN1 knockdown using an adeno-associated virus serotype 9 packaged shRNA-mBIN1 restores the nanoscale distribution and clustering plasticity of ryanodine receptors and recovers Ca 2+ transient amplitudes and cardiac systolic function toward youthful levels. Enhanced systolic function correlates with increased phosphorylation of the myofilament protein cardiac myosin binding protein-C. These results reveal BIN1 knockdown as a novel therapeutic strategy to rejuvenate the aging myocardium.
Keyphrases
- left ventricular
- blood pressure
- binding protein
- heart failure
- high fat diet induced
- cell proliferation
- oxidative stress
- randomized controlled trial
- liver failure
- pulmonary hypertension
- escherichia coli
- clinical trial
- poor prognosis
- genome wide
- atrial fibrillation
- protein kinase
- electronic health record
- subarachnoid hemorrhage
- respiratory failure
- drug induced
- heat stress
- adipose tissue
- deep learning
- acute respiratory distress syndrome
- wild type